Corrado Advisors, LLC Harrow Health, Inc. Transaction History

Corrado Advisors, LLC

$132 Million
Q3 2024

A detailed history of Corrado Advisors, LLC transactions in Harrow Health, Inc. stock. As of the latest transaction made, Corrado Advisors, LLC holds 7,366 shares of HROW stock, worth $287,347. This represents 0.25% of its overall portfolio holdings.

Number of Shares

7,366

Holding current value

$287,347

% of portfolio

0.25%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 01, 2024	BUY	$20.85 - $46.47 $153,581 - $342,298	7,366 New	7,366 $331,000
Q4 2023 Feb 01, 2024	SELL	$8.1 - $16.36 $31,557 - $63,738	-3,896 Reduced 27.02%	10,521 $117,000
Q1 2023 May 03, 2023	SELL	$13.84 - $21.46 $26,254 - $40,709	-1,897 Reduced 11.63%	14,417 $305,000
Q4 2022 Feb 09, 2023	SELL	$10.28 - $14.78 $29,256 - $42,063	-2,846 Reduced 14.85%	16,314 $240,000
Q4 2021 Jan 14, 2022	SELL	$8.5 - $12.0 $39,100 - $55,200	-4,600 Reduced 19.36%	19,160 $166,000
Q3 2021 Oct 13, 2021	BUY	$6.99 - $10.6 $10,939 - $16,589	1,565 Added 7.05%	23,760 $216,000
Q2 2021 Jul 20, 2021	SELL	$6.68 - $11.07 $29,291 - $48,541	-4,385 Reduced 16.5%	22,195 $206,000
Q1 2021 Apr 15, 2021	SELL	$6.26 - $11.03 $31,300 - $55,150	-5,000 Reduced 15.83%	26,580 $179,000
Q4 2020 Jan 28, 2021	SELL	$4.76 - $6.93 $32,320 - $47,054	-6,790 Reduced 17.7%	31,580 $217,000
Q3 2020 Oct 07, 2020	SELL	$4.71 - $7.36 $23,691 - $37,020	-5,030 Reduced 11.59%	38,370 $214,000
Q2 2020 Jul 07, 2020	BUY	$3.61 - $6.47 $15,992 - $28,662	4,430 Added 11.37%	43,400 $226,000
Q1 2020 Apr 06, 2020	SELL	$3.5 - $7.31 $27,597 - $57,639	-7,885 Reduced 16.83%	38,970 $148,000
Q4 2019 Jan 15, 2020	SELL	$4.6 - $7.88 $4,991 - $8,549	-1,085 Reduced 2.26%	46,855 $365,000
Q3 2019 Oct 08, 2019	SELL	$4.89 - $8.0 $32,562 - $53,272	-6,659 Reduced 12.2%	47,940 $269,000
Q2 2019 Jul 10, 2019	BUY	$4.2 - $8.7 $229,315 - $475,011	54,599 New	54,599 $475,000

Others Institutions Holding HROW

# of Institutions

176

Shares Held

21.4M

Call Options Held

845K

Put Options Held

717K

View Full List

About HARROW HEALTH, INC.

Ticker HROW
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 27,070,000
Market Cap $1.06B
Description
Harrow Health, Inc. operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business; and DEXYCU for the treatment of post-operative inflammation. The company also holds equity interests in Surface Ophthalmics, Inc., a clinical-stage pharmaceutical company tha...

More about HROW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Corrado Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Corrado Advisors, LLC with notifications on news.

Account

Corrado Advisors, LLC Harrow Health, Inc. Transaction History